LITHIUM CITRATE TETRAHYDRATE manufacturers
|
| | LITHIUM CITRATE TETRAHYDRATE Basic information |
| Product Name: | LITHIUM CITRATE TETRAHYDRATE | | Synonyms: | TRI-LITHIUM CITRATE TETRAHYDRATE;LITHIUM CITRATE TETRAHYDRATE;CITRIC ACID TRILITHIUM SALT;CITRIC ACID, TRILITHIUM SALT TETRAHYDRATE;CITRIC ACID, 3LI, TETRAHYDRATE;Lithium citrate tribasic tetrahydrate;Tri-LithiumCitrateGr(Tetrahydrate);Lithium citrate tetrahydrate (tribasic) | | CAS: | 6080-58-6 | | MF: | C6H13Li3O11 | | MW: | 281.98 | | EINECS: | 612-032-8 | | Product Categories: | GLYSET | | Mol File: | 6080-58-6.mol |  |
| | LITHIUM CITRATE TETRAHYDRATE Chemical Properties |
| Melting point | 112 °C | | density | 1.64 at 20℃ | | bulk density | 420kg/m3 | | storage temp. | 2-8°C | | solubility | H2O: 1 M at 20 °C, clear, colorless | | form | Fine Crystalline Powder | | color | White | | PH | 8.0-9.5 (25℃, 1M in H2O) | | Odor | Odorless | | PH Range | 8.0 - 9.5 at 209.8 g/l at 25 °C | | Water Solubility | 209.8 g/l at 20 °C | | λmax | λ: 260 nm Amax: 0.040
λ: 280 nm Amax: 0.016 | | Merck | 13,5552 | | Stability: | Stable. Incompatible with strong oxidizing agents, reducing agents, bases. | | InChI | 1S/C6H8O7.3Li.4H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;4*1H2/q;3*+1;;;;/p-3 | | InChIKey | HXGWMCJZLNWEBC-UHFFFAOYSA-K | | SMILES | [Li+].[Li+].[Li+].O.O.O.O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | | LogP | -1.72--1.67 at 20-25℃ | | CAS DataBase Reference | 6080-58-6(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 1 | | F | 3 | | HS Code | 29181500 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral |
| | LITHIUM CITRATE TETRAHYDRATE Usage And Synthesis |
| Chemical Properties | White crystalline powder | | Uses | alpha-glucosidase inhibitor, antidiabetic | | Uses | Lithium citrate is useful as a potential therapeutic for Canavan disease due to aspartoacylase deficiency or aminoacylase 2 deficiency. | | Application | Citric acid trilithium salt tetrahydrate is a pharmaceutical structural material commonly used in the determination of amino acids by high-performance liquid chromatography gradient elution. | | Definition | ChEBI: A hydrate that is the tetrahydrate form of lithium citrate. It is used as a source of lithium for the treatment of anxiety disorders, bipolar disorder, and depression. | | Brand name | Lithonate (Solvay Pharmaceuticals). |
| | LITHIUM CITRATE TETRAHYDRATE Preparation Products And Raw materials |
|